Gamida Cell Ltd. is a clinical stage biopharmaceutical company, which engages in the development of cell therapies that are designed to cure blood cancer and rare serious hematologic diseases. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.
SHORT INTEREST
30.41K 07/31/19
P/E Current
-0.33
P/E Ratio (with extraordinary items)
-1.65
Average Recommendation: BUY
Average Target Price: 18.00
SHORT INTEREST
30.41K 07/31/19
P/E Current
-0.33
P/E Ratio (with extraordinary items)
-1.65
Average Recommendation: BUY
Average Target Price: 18.00
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media